Chong Kun Dang develop novel formulation technology for amlodipine

Published: 2004-08-18 06:58:00
Updated: 2004-08-18 06:58:00
Chong Kun Dang Pharmaceutical Co. said it has filed a Korean patent application (No. 10-2004-0048208) related to a process of synthesizing high-purity amlodipine maleate with less impurities.

The core micro-coating formulation technology, which was independently developed by Chong Kung Dang th...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.